
Clinically Proven to Significantly Reduce Nail Damage
At Polybalm, we believe in evidence-based solutions. That’s why our formula has undergone rigorous clinical trials to ensure its effectiveness and safety.

The Polybalm Clinical Trials*
Chemotherapy can cause significant nail damage, leading to brittleness, discoloration, and discomfort. To address this issue, researchers conducted the Polybalm Clinical Trial, published in May 2018, to evaluate the effectiveness of Polybalm—a plant-based nail balm—in protecting nails during chemotherapy.
About the Study
The trial was a randomized, double-blind, placebo-controlled study, ensuring high scientific validity. Cancer patients undergoing chemotherapy were divided into two groups:
✔ Polybalm Group – Applied the botanical-based balm to their nails.
✔ Placebo Group – Used a non-active balm for comparison.
Researchers monitored nail strength, appearance, and discomfort throughout treatment.
Key Findings
-
Significant Nail Protection: Patients using Polybalm experienced less nail breakage, discoloration, and pain than those using the placebo.
-
Natural & Safe Formula: The botanical ingredients provided a gentle yet effective solution without major side effects.
-
Improved Quality of Life: Healthier nails helped patients feel more comfortable and confident during chemotherapy.
Why This Matters
For patients, Polybalm offers a natural and scientifically backed way to maintain nail health during chemotherapy.
For healthcare providers, this trial supports Polybalm as a trusted, evidence-based option to help patients manage treatment side effects.
Clinical Evidence & Research
The Polybalm Clinical Trial (2018)

A randomized, double-blind, placebo-controlled study was conducted over two years with 61 patients undergoing chemotherapy for breast and prostate cancer.
✔ Polybalm® Group: 29 out of 30 patients (97%) experienced virtually no nail damage.
❌ Placebo Group: More than half experienced significant nail deterioration.
⚠ No adverse effects were reported with either balm.
Clinical Trial: Proven Protection for Nails!
A rigorous clinical trial conducted at Cambridge University-affiliated hospitals tested Polybalm’s effectiveness in preventing chemotherapy-related nail damage.
Trial Design
📌 Participants: 61 patients undergoing chemotherapy for breast or prostate cancer.
📌 Method: Patients were randomly assigned (50:50) to use either:
✔ Polybalm® – A plant-based nail balm.
✔ Placebo – A simple petroleum-based moisturizer.
📌 Assessment: Nail health was evaluated by patients, physicians, and independent reviewers using validated scoring tools and photographs.
Results
✅ Polybalm® Group: Virtually no nail damage in 29 out of 30 patients. Some even reported improved nail quality.
❌ Placebo Group: More than half experienced significant nail damage and distress.
⚠ No adverse reactions were reported with either balm.
Conclusion
The polyphenol-rich formula in Polybalm® significantly reduced chemotherapy-related nail damage, improving comfort and quality of life. This groundbreaking trial provides strong evidence that Polybalm® is a safe, effective solution for protecting nails during cancer treatment.
The Power of Nature:
Polybalm’s Unique Formula
Polybalm is carefully formulated using 100% natural plant-based ingredients, chosen for their protective, antimicrobial, anti-fungal and nourishing properties. This unique natural botanical blend helps maintain the look of healthy nails during the toughest times for finger and toe nails without harsh chemicals or synthetic additives.
Expert Insights:
Dr. Thomas on Polybalm
Hear directly from Dr. Robert Thomas, lead researcher of the Polybalm Clinical Trial, as he discusses the science behind Polybalm and its benefits for chemotherapy patients.
🎥 Watch the video to learn:
✅ How Polybalm helps protect nails during chemotherapy
✅ The key findings of the 2018 clinical trial
✅ Why healthcare professionals and patients trust Polybalm
"Our research has shown that Polybalm provides a natural, safe, and effective way to prevent chemotherapy-induced nail damage." – Doctor Robert Thomas